Compare $BSX vs $DXCM | Chartloom

Compare

$BSX vs $DXCM

Boston Scientific Corp · Dexcom Inc

BSX

Boston Scientific Corp

DXCM

Dexcom Inc

Compare $BSX vs $DXCM

Comparing Boston Scientific Corp and Dexcom Inc

BSXBoston Scientific Corp

DXCMDexcom Inc

BSXBoston Scientific Corp

Market cap

$63.51B

P/E (TTM)

17.15x

Forward P/E (NTM)

13.03x

Forward P/S (NTM)

2.93x

Rev growth (TTM)

13.5%

YTD performance

-54.9%

52W performance

-55.9%

FCF yield

5.7%

DXCMDexcom Inc

Market cap

$32.46B

P/E (TTM)

32.82x

Forward P/E (NTM)

29.31x

Forward P/S (NTM)

5.79x

Rev growth (TTM)

15.5%

YTD performance

26.4%

52W performance

24.1%

FCF yield

4.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BSX

DXCM

Detailed metrics comparison

BSX

Boston Scientific Corp

DXCM

Dexcom Inc

Market Cap

BSX$63.51B

DXCM$32.46B

Enterprise Value

BSX$75.60B

DXCM$32.65B

Price

BSX$42.73

DXCM$84.11

P/E Ratio

BSX17.15x

DXCM32.82x

P/S Ratio

BSX3.02x

DXCM6.53x

EV/Sales

BSX3.60x

DXCM6.57x

EV/EBITDA

BSX12.63x

DXCM21.12x

P/B Ratio

BSX2.48x

DXCM12.29x

P/FCF Ratio

BSX17.52x

DXCM23.10x

EV/FCF

BSX20.85x

DXCM23.24x

PEG Ratio

BSX0.37x

DXCM1.54x

Forward P/E (NTM)

BSX13.03x

DXCM29.31x

Forward P/S (NTM)

BSX2.93x

DXCM5.79x

Revenue (TTM)

BSX$21.00B

DXCM$4.97B

Revenue Growth (YoY)

BSX13.5%

DXCM15.5%

Forward Rev Growth

BSX4.2%

DXCM10.8%

Gross Margin (TTM)

BSX69.5%

DXCM64.3%

Operating Margin (TTM)

BSX19.8%

DXCM22.9%

EBITDA Margin (TTM)

BSX27.7%

DXCM30.1%

Net Margin (TTM)

BSX17.5%

DXCM20.1%

FCF Margin (TTM)

BSX17.3%

DXCM28.3%

Net Income (TTM)

BSX$3.68B

DXCM$1,000M

FCF (TTM)

BSX$3.63B

DXCM$1.41B

EPS (TTM)

BSX$2.49

DXCM$2.56

ROE (TTM)

BSX14.9%

DXCM36.2%

ROA (TTM)

BSX8.3%

DXCM14.8%

ROIC (TTM)

BSX10.1%

DXCM22.9%

Cash

BSX$539M

DXCM$1.11B

Debt

BSX$12.62B

DXCM$1.30B

Net Cash/Debt

BSX$-12.09B

DXCM$-190M

Current Ratio (TTM)

BSX1.24x

DXCM1.73x

Quick Ratio (TTM)

BSX0.68x

DXCM1.40x

Debt/Equity (TTM)

BSX0.51x

DXCM0.49x

Debt/Assets (TTM)

BSX0.0%

DXCM0.0%

Interest Coverage (TTM)

BSXN/A

DXCMN/A

Net Debt/EBITDA (TTM)

BSX0.00x

DXCM0.00x

Beta

BSX0.59

DXCM1.44

52W Performance

BSX-55.9%

DXCM24.1%

YTD Performance

BSX-54.9%

DXCM26.4%

% from 52W High

BSX-59.6%

DXCM-9.2%

% from 52W Low

BSX3.2%

DXCM55.4%

Asset Turnover (TTM)

BSX0.48x

DXCM0.74x

FCF Yield (TTM)

BSX5.7%

DXCM4.3%

Earnings Yield (TTM)

BSX5.8%

DXCM3.1%

Dividend Yield (TTM)

BSXN/A

DXCMN/A

Rule of 40

BSX30.8

DXCM43.8

EV/GP/RG

BSX1.55

DXCM0.77

Ticker research

View BSX research View DXCM research

Metric	BSX Boston Scientific Corp	DXCM Dexcom Inc
Market & Valuation
Market Cap	$63.51B	$32.46B
Enterprise Value	$75.60B	$32.65B
Price	$42.73	$84.11
P/E Ratio	17.15x	32.82x
P/S Ratio	3.02x	6.53x
EV/Sales	3.60x	6.57x
EV/EBITDA	12.63x	21.12x
P/B Ratio	2.48x	12.29x
P/FCF Ratio	17.52x	23.10x
EV/FCF	20.85x	23.24x
PEG Ratio	0.37x	1.54x
Forward P/E (NTM)	13.03x	29.31x
Forward P/S (NTM)	2.93x	5.79x
Revenue & Growth
Revenue (TTM)	$21.00B	$4.97B
Revenue Growth (YoY)	13.5%	15.5%
Forward Rev Growth	4.2%	10.8%
Profitability
Gross Margin (TTM)	69.5%	64.3%
Operating Margin (TTM)	19.8%	22.9%
EBITDA Margin (TTM)	27.7%	30.1%
Net Margin (TTM)	17.5%	20.1%
FCF Margin (TTM)	17.3%	28.3%
Net Income (TTM)	$3.68B	$1,000M
FCF (TTM)	$3.63B	$1.41B
EPS (TTM)	$2.49	$2.56
ROE (TTM)	14.9%	36.2%
ROA (TTM)	8.3%	14.8%
ROIC (TTM)	10.1%	22.9%
Financial Health
Cash	$539M	$1.11B
Debt	$12.62B	$1.30B
Net Cash/Debt	$-12.09B	$-190M
Current Ratio (TTM)	1.24x	1.73x
Quick Ratio (TTM)	0.68x	1.40x
Debt/Equity (TTM)	0.51x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	1.44
52W Performance	-55.9%	24.1%
YTD Performance	-54.9%	26.4%
% from 52W High	-59.6%	-9.2%
% from 52W Low	3.2%	55.4%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	0.74x
FCF Yield (TTM)	5.7%	4.3%
Earnings Yield (TTM)	5.8%	3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.8	43.8
EV/GP/RG	1.55	0.77
Ticker research	View BSX research	View DXCM research

Valuation

P/E Ratio

BSX

17.15x

DXCM

32.82x

P/S Ratio

BSX

3.02x

DXCM

6.53x

EV/FCF

BSX

20.85x

DXCM

23.24x

Growth & revenue

Revenue Growth TTM

DXCM

15.5%

BSX

13.5%

Forward Revenue Growth

DXCM

10.8%

BSX

4.2%

Profitability & performance

Gross Margin

BSX

69.5%

DXCM

64.3%

ROE

DXCM

36.2%

BSX

14.9%

FCF Yield %

BSX

5.7%

DXCM

4.3%

52-Week Performance

DXCM

24.1%

BSX

-55.9%

Detailed metrics comparison

BSX

Boston Scientific Corp

DXCM

Dexcom Inc

Market Cap

BSX$63.51B

DXCM$32.46B

Enterprise Value

BSX$75.60B

DXCM$32.65B

Price

BSX$42.73

DXCM$84.11

P/E Ratio

BSX17.15x

DXCM32.82x

P/S Ratio

BSX3.02x

DXCM6.53x

EV/Sales

BSX3.60x

DXCM6.57x

EV/EBITDA

BSX12.63x

DXCM21.12x

P/B Ratio

BSX2.48x

DXCM12.29x

P/FCF Ratio

BSX17.52x

DXCM23.10x

EV/FCF

BSX20.85x

DXCM23.24x

PEG Ratio

BSX0.37x

DXCM1.54x

Forward P/E (NTM)

BSX13.03x

DXCM29.31x

Forward P/S (NTM)

BSX2.93x

DXCM5.79x

Revenue (TTM)

BSX$21.00B

DXCM$4.97B

Revenue Growth (YoY)

BSX13.5%

DXCM15.5%

Forward Rev Growth

BSX4.2%

DXCM10.8%

Gross Margin (TTM)

BSX69.5%

DXCM64.3%

Operating Margin (TTM)

BSX19.8%

DXCM22.9%

EBITDA Margin (TTM)

BSX27.7%

DXCM30.1%

Net Margin (TTM)

BSX17.5%

DXCM20.1%

FCF Margin (TTM)

BSX17.3%

DXCM28.3%

Net Income (TTM)

BSX$3.68B

DXCM$1,000M

FCF (TTM)

BSX$3.63B

DXCM$1.41B

EPS (TTM)

BSX$2.49

DXCM$2.56

ROE (TTM)

BSX14.9%

DXCM36.2%

ROA (TTM)

BSX8.3%

DXCM14.8%

ROIC (TTM)

BSX10.1%

DXCM22.9%

Cash

BSX$539M

DXCM$1.11B

Debt

BSX$12.62B

DXCM$1.30B

Net Cash/Debt

BSX$-12.09B

DXCM$-190M

Current Ratio (TTM)

BSX1.24x

DXCM1.73x

Quick Ratio (TTM)

BSX0.68x

DXCM1.40x

Debt/Equity (TTM)

BSX0.51x

DXCM0.49x

Debt/Assets (TTM)

BSX0.0%

DXCM0.0%

Interest Coverage (TTM)

BSXN/A

DXCMN/A

Net Debt/EBITDA (TTM)

BSX0.00x

DXCM0.00x

Beta

BSX0.59

DXCM1.44

52W Performance

BSX-55.9%

DXCM24.1%

YTD Performance

BSX-54.9%

DXCM26.4%

% from 52W High

BSX-59.6%

DXCM-9.2%

% from 52W Low

BSX3.2%

DXCM55.4%

Asset Turnover (TTM)

BSX0.48x

DXCM0.74x

FCF Yield (TTM)

BSX5.7%

DXCM4.3%

Earnings Yield (TTM)

BSX5.8%

DXCM3.1%

Dividend Yield (TTM)

BSXN/A

DXCMN/A

Rule of 40

BSX30.8

DXCM43.8

EV/GP/RG

BSX1.55

DXCM0.77

Ticker research

View BSX research View DXCM research

Metric	BSX Boston Scientific Corp	DXCM Dexcom Inc
Market & Valuation
Market Cap	$63.51B	$32.46B
Enterprise Value	$75.60B	$32.65B
Price	$42.73	$84.11
P/E Ratio	17.15x	32.82x
P/S Ratio	3.02x	6.53x
EV/Sales	3.60x	6.57x
EV/EBITDA	12.63x	21.12x
P/B Ratio	2.48x	12.29x
P/FCF Ratio	17.52x	23.10x
EV/FCF	20.85x	23.24x
PEG Ratio	0.37x	1.54x
Forward P/E (NTM)	13.03x	29.31x
Forward P/S (NTM)	2.93x	5.79x
Revenue & Growth
Revenue (TTM)	$21.00B	$4.97B
Revenue Growth (YoY)	13.5%	15.5%
Forward Rev Growth	4.2%	10.8%
Profitability
Gross Margin (TTM)	69.5%	64.3%
Operating Margin (TTM)	19.8%	22.9%
EBITDA Margin (TTM)	27.7%	30.1%
Net Margin (TTM)	17.5%	20.1%
FCF Margin (TTM)	17.3%	28.3%
Net Income (TTM)	$3.68B	$1,000M
FCF (TTM)	$3.63B	$1.41B
EPS (TTM)	$2.49	$2.56
ROE (TTM)	14.9%	36.2%
ROA (TTM)	8.3%	14.8%
ROIC (TTM)	10.1%	22.9%
Financial Health
Cash	$539M	$1.11B
Debt	$12.62B	$1.30B
Net Cash/Debt	$-12.09B	$-190M
Current Ratio (TTM)	1.24x	1.73x
Quick Ratio (TTM)	0.68x	1.40x
Debt/Equity (TTM)	0.51x	0.49x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	1.44
52W Performance	-55.9%	24.1%
YTD Performance	-54.9%	26.4%
% from 52W High	-59.6%	-9.2%
% from 52W Low	3.2%	55.4%
Efficiency & Yields
Asset Turnover (TTM)	0.48x	0.74x
FCF Yield (TTM)	5.7%	4.3%
Earnings Yield (TTM)	5.8%	3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.8	43.8
EV/GP/RG	1.55	0.77
Ticker research	View BSX research	View DXCM research